Olivier Kosmider

Mutation in <i>TET2</i> in Myeloid Cancers

François Delhommeau, Sabrina Dupont, Véronique Della Valle et al. · New England Journal of Medicine · 2009 · 1.7K citations · Full text

Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19

Aymeric Silvin, Nicolas Chapuis, Garett Dunsmore et al. · Cell · 2020 · 898 citations · Full text

Mild Covid-19, Hematological Malignancy, Hematology +5

Molecular International Prognostic Scoring System for Myelodysplastic Syndromes

Elsa Bernard, Heinz Tuechler, Peter L. Greenberg et al. · NEJM Evidence · 2022 · 746 citations · Full text

Mixed-phenotype Acute Leukemia, Prognosis, Genetic Epidemiology +20

Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes

Elsa Bernard, Yasuhito Nannya, Robert P. Hasserjian et al. · Nature Medicine · 2020 · 606 citations · Full text

Hematological Malignancy, Chromatin, Genome Stability +11

Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia

Raphaël Itzykson, Olivier Kosmider, Aline Renneville et al. · Journal of Clinical Oncology · 2013 · 537 citations